Plus Therapeutics | CYTX - Ebitda

Stock Price
0.30
Daily Change
-0.01 -4.21%
Monthly
13.89%
Yearly
-79.44%
Q1 Forecast
0.29

Plus Therapeutics reported $-4.56M in EBITDA for its fiscal quarter ending in March of 2023.





Ebitda Change Date
Baxter International USD 426M 36M Sep/2025
Dr.Reddys Laboratories INR 20.89B 117M Dec/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Infinity Pharmaceuticals USD -10.01M 1.39M Jun/2023
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Sanofi EUR 4.84B 2.95B Sep/2025
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025